Carti Cancer Center — Little Rock, Arkansas

Carti Cancer Center is a clinical research site located in Little Rock, Arkansas, United States 72205.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Carti Cancer Center has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC).

Sponsors: Replimune Inc., BeiGene, Odonate Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Carti Cancer Center?

Carti Cancer Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Carti Cancer Center conducted?

Carti Cancer Center has 5 clinical trials on record, with 2 currently active. Their work covers Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC).

Is Carti Cancer Center accredited by Crixeo Health?

Yes — Carti Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Carti Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.